External prescription for controlling temporal arteritis and preparation method thereof

A technology of arteritis and prescriptions, which is applied in the field of external medicine for the treatment of eye diseases, can solve the problems of not introducing ophthalmology textbooks, etc., and achieve the effect of complete control of eye inflammation, good decoction effect, and good protection

Inactive Publication Date: 2021-02-26
郭照高
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Temporal arteritis was named by American scientists. So far, no ophthalmology textbooks have been introduced. Most eye hospitals do not have special departments. However, temporal arteritis is a high-risk factor for blindness and the fuse of various eye diseases.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046]An external prescription for controlling temporal arteritis, the raw material of which is composed of the following ingredients in percent by mass:

[0047]Pengzi Cai 30%, Coptis 20%, Golden Deng Teng 15%, Shijue Ming 10%, Bear Gallbladder 3%, Panax Notoginseng 7%, Safflower 5%, Mao Dongqing 6%, Pentaketone 3%, Borneol 1%.

Embodiment 2

[0049]A topical prescription for controlling temporal arteritis. Its raw materials are composed of the following ingredients in percent by mass:

[0050]Pengzi Cai 35%, Coptis 10%, Golden Deng Teng 5%, Shijue Ming 15%, Bear Gallbladder 5%, Panax Notoginseng 10%, Safflower 10%, Mao Dongqing 6%, Pentaketone 2%, Borneol 2%.

Embodiment 3

[0052]A topical prescription for controlling temporal arteritis. Its raw materials are composed of the following ingredients in percent by mass:

[0053]Pengzi Cai 15%, Coptis 25%, Golden Deng Teng 20%, Shi Cassia 5%, Bear Gallbladder 10%, Panax Notoginseng 3%, Safflower 7%, Mao Dongqing 10%, Pentaketone 1%, Borneol 4%.

[0054]The preparation method of the external prescription for controlling temporal arteritis includes the following steps:

[0055](1) Prepare the raw materials in the above mass percentages and prepare them into powder. After the tincture is prepared, filter out the clear liquid of Pentadecone and Borneol;

[0056](2) Weigh the powders of other raw materials except pentadecone and borneol and put them into the preparation container, and immerse them with freshly prepared 60% edible alcohol; according to the mass-volume ratio of the raw material powder and the alcohol solution 10g:20ml, Add 2 / 3 of the alcohol in the first immersion liquid, stir well and place it in an undergro...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an external prescription for controlling temporal arteritis and a preparation method thereof. Raw materials of the external prescription are prepared from the following components in percentage by mass: 10%-35% of galium verum, 2%-25% of coptis chinensis, 2%-25% of cuscuta japonica, 2%-30% of concha haliotidis, 0.1%-10% of bear gall, 2%-25% of pseudo-ginseng, 2%-20% of safflower, 2%-30% of pubescent holly root, 0.1%-5% of pentadecanone and 0.1%-5% of borneol. The preparation method mainly comprises the step of dipping through alcohol. The external prescription is convenient to use, has a very good effect on various types of eye inflammations, can completely control the eye inflammations and reverse visual impairment aiming at temporal arteritis eye diseases, and canrealize reseeing of blinded eyes to be bright.

Description

Technical field[0001]The invention relates to an external medicine for treating eye diseases, in particular to an external prescription for controlling temporal arteritis and a preparation method thereof.Background technique[0002]With the microscopic changes in air composition, temporal arteritis of urban residents is increasing year by year. According to the solar terms, the hottest period of the year is the hottest period of the year from the great heat and the beginning of autumn, and it is also the frequent period of onset of temporal arteritis.[0003]The high temperature is dry, and the concentration of fine particles suspended in the air is high. At this time, just a little attention to the dust on the mirror surface of the home will find that the glass is more difficult to wipe clean than usual, but this phenomenon does not exist in the rural mountain areas with clean air. In the kitchen at home, due to gas ignition, temperature adjustment, and flameout, the gas is not fully b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/74A61K47/10A61K47/06A61P9/14A61P27/02A61K35/618A61K35/413
CPCA61K35/413A61K35/618A61K36/185A61K36/258A61K36/286A61K36/39A61K36/718A61K36/74A61K47/06A61K47/10A61K2236/333A61P9/14A61P27/02A61K2300/00
Inventor 郭照高
Owner 郭照高
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap